Screener
Supernus Pharmaceuticals SUPN Business Segments — General and administrative expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cost of revenues | 23,391 | 15,763 |
| Selling expenses | 66,278 | 42,614 |
| Marketing expenses | 20,697 | 20,664 |
| General and administrative expenses | 38,198 | 26,666 |
| Research and development expenses | ||
| External development program expenses: | ||
| ONAPGO | 261 | 472 |
| SPN-820 | 1,849 | 4,763 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Supernus Pharmaceuticals's business segments — general and administrative expenses?
- Supernus Pharmaceuticals (SUPN) reported business segments — general and administrative expenses of $38.2M in Q1 2026.
- How has Supernus Pharmaceuticals's business segments — general and administrative expenses changed year-over-year?
- Supernus Pharmaceuticals's business segments — general and administrative expenses increased by 43.2% year-over-year, from $26.67M to $38.2M.
- What is the long-term trend for Supernus Pharmaceuticals's business segments — general and administrative expenses?
- Over 3 years (2022 to 2025), Supernus Pharmaceuticals's business segments — general and administrative expenses has grown at a 4.6% compound annual growth rate (CAGR), from $109.43M to $125.36M.
- What does business segments — general and administrative expenses mean?
- Encompasses the overhead costs required to support the segment's operations, including management, legal, and administrative functions. Tracking these expenses provides insight into the company's operational leverage and cost management discipline.
Ask your AI about Supernus Pharmaceuticals's business segments — general and administrative expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude